Intellia Therapeutics Inc
SWB:38I
Intellia Therapeutics Inc
SWB:38I
Price:
11.62
EUR
-1.36%
Market Cap:
€3.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Intellia Therapeutics Inc
SWB:38I
|
US |
|
B
|
Bank of America Corp
F:NCB
|
US |
|
Svenska Cellulosa SCA AB
OTC:SCABY
|
SE |
|
S
|
Sirius XM Holdings Inc
DUS:RDO
|
US |
|
Baozun Inc
NASDAQ:BZUN
|
CN |
|
B
|
BioLife Solutions Inc
F:BJX1
|
US |
|
CoStar Group Inc
F:RLG
|
US |
|
F
|
Fosterville South Exploration Ltd
OTC:FSXLF
|
CA |
|
T
|
Triumph New Energy Co Ltd
OTC:LUOYF
|
CN |
|
dentalcorp Holdings Ltd
OTC:DNTCF
|
CA |
|
G
|
GEA Group AG
F:G1A
|
DE |
|
O
|
Otto Energy Ltd
F:O1E
|
AU |
|
Equinix Inc
NASDAQ:EQIX
|
US |
|
D
|
Discover Financial Services
XBER:DC7
|
US |
|
C
|
Coats Group PLC
F:4TC
|
UK |
|
Oracle Financial Services Software Ltd
NSE:OFSS
|
IN |
|
Aviva PLC
LSE:AV
|
UK |
|
V
|
Visteon Corp
XMUN:VS51
|
US |
|
J
|
JCDecaux SA
F:DCS
|
FR |
|
C
|
China Merchants Port Holdings Co Ltd
XMUN:CPM
|
HK |
|
R
|
Ross Stores Inc
BMV:ROST
|
US |
|
V
|
Visa Inc
BMV:V
|
US |
Wall St Price Targets
38I Price Targets Summary
Intellia Therapeutics Inc
Intellia Therapeutics Inc
Wall Street analysts forecast 38I stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 38I is 21 EUR with a low forecast of 4.21 EUR and a high forecast of 92.88 EUR.
Lowest Forecast
Price Target
4.21
EUR
64% Downside
Average Forecast
Price Target
21
EUR
81% Upside
Highest Forecast
Price Target
92.88
EUR
699% Upside
Intellia Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 38I's stock price target?
Price Target
21
EUR
21
EUR
According to Wall Street analysts, the average 1-year price target for 38I is 21 EUR with a low forecast of 4.21 EUR and a high forecast of 92.88 EUR.
What is the Revenue forecast for Intellia Therapeutics Inc?
Projected CAGR
51%
51%
Over the last 10 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 8 years is 51%.
